Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.4%

9 terminated/withdrawn out of 49 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

35%

17 trials in Phase 3/4

Results Transparency

0 of 36 completed trials have results

Key Signals

1 recruiting7 terminated

Enrollment Performance

Analytics

Phase 2

15(30.6%)

Phase 3

14(28.6%)

N/A

11(22.4%)

Phase 1

6(12.2%)

Phase 4

3(6.1%)

49Total

Phase 2(15)

Phase 3(14)

N/A(11)

Phase 1(6)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials

NCT07089329Phase 3Completed

Efficacy of Striatin in Malnourished Children

Role: collaborator

NCT07475065Phase 2Not Yet Recruiting

The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy

Role: collaborator

NCT07420491Phase 3Completed

The Efficacy and Safety of Reconyl in Acute Cough Treatment

Role: lead

NCT06558071Phase 3Completed

Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers

Role: lead

NCT05248802Phase 3Completed

DLBS2411 Treatment For Functional Dyspepsia

Role: lead

NCT07075289Phase 4Completed

Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo

Role: collaborator

NCT06933862Not ApplicableNot Yet Recruiting

Effects of Channa Striata Extract on Intestinal Inflammation and Nutritional Status in Malnutritional Toddlers After Albendazole Therapy in South Bangka District

Role: collaborator

NCT06100432Phase 4Active Not Recruiting

Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males

Role: collaborator

NCT06817811Phase 1Completed

Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet

Role: lead

NCT06497439Phase 2Completed

Efficacy and Safety of Silfamin for Common Cold

Role: lead

NCT06558006Phase 2Completed

Safety and Efficacy Predimenol for Headache

Role: lead

NCT06510257Phase 2Completed

Safety and Efficacy Reconyl for Cough With/Without Sore Throat

Role: lead

NCT06127225Phase 2Completed

Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)

Role: lead

NCT06525155Phase 3Recruiting

Effect GnRH Agonist Administration in Endometriosis Cyst Patients

Role: collaborator

NCT06558058Phase 1Completed

Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets

Role: lead

NCT06558032Phase 1Completed

Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets

Role: lead

NCT06558045Phase 1Completed

Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets

Role: lead

NCT02133521Phase 2Terminated

DLBS1033 for Acute Ischemic Stroke Patients

Role: lead

NCT06127212Not ApplicableCompleted

Bioequivalence Study of Dapagliflozin 10 mg Film-coated Tablets

Role: lead

NCT02976701Phase 2Terminated

Effect of DLBS1033 After Primary PCI in Patients With STE-ACS

Role: lead